| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $44.6M | — | +32.1% |
| Cost of Revenue | $21.9M | — | +14.5% |
| Gross Profit | $22.7M | — | +55.0% |
| R&D Expense | $7.9M | — | -15.5% |
| SG&A Expense | $8.0M | — | +26.8% |
| Operating Income | -$1.2M | — | +87.8% |
| Interest Expense | $2.0M | — | +4.0% |
| Pre-tax Income | -$3.0M | — | +74.3% |
| Income Tax | $408K | — | +7.9% |
| Net Income | -$3.4M | — | +71.7% |
| EPS (Basic) | -$0.12 | — | +71.4% |
| EPS (Diluted) | -$0.12 | — | +71.4% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Accounts Receivable | $49.6M | +23.2% | +39.2% |
| Inventory | $25.9M | -6.0% | -31.1% |
| Current Assets | $94.2M | +3.8% | -21.6% |
| Total Assets | $138.4M | +1.0% | -13.1% |
| Current Liabilities | $141.9M | +3.3% | +6.3% |
| Long-term Debt | $66.4M | +0.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$4.4M | — | +9.2% |
| Capital Expenditures | $69K | — | -68.2% |
| Investing Cash Flow | -$772K | — | +53.2% |
| Financing Cash Flow | -$13K | — | +98.0% |
| Free Cash Flow | -$4.4M | — | +11.8% |
| -0.8% |
| Total Liabilities | $177.1M | +2.3% | +2.7% |
| Stockholders' Equity | -$38.6M | -7.4% | -194.4% |